A carregar...
Colorectal Cancer Treatment: What’s Next? (or: Is There Life After EGFR and VEGF?)
In the past 10 to 15 years, the number of approved agents for treatment of colorectal cancer has expanded from only one (in 1995) to seven (as of 2006), with the most recent additions being the targeted agents cetuximab, bevacizumab, and panitumumab. While real progress has been made, these advances...
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
International Society of Gastrointestinal Oncology
2008
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2661544/ https://ncbi.nlm.nih.gov/pubmed/19343143 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|